Journal of the American Society of Nephrology, Vol 4, 1127-1132, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors

RM Edwards and W Trizna
Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939.

The inhibition of nitric oxide production has been shown to reduce RBF. The effects of the nitric oxide synthase inhibitors, N omega-nitro-L- arginine and NG-monomethyl-L-arginine, on afferent and efferent arterioles isolated from rabbit kidneys were examined. Under basal conditions, N omega-nitro-L-arginine (10(-7) to 10(-3) M) had no effect on efferent arteriole lumen diameter but caused a 40% decrease in the lumen diameter of afferent arterioles. In afferent and efferent arterioles precontracted with norepinephrine, N omega-nitro-L-arginine and NG-monomethyl-L-arginine (3 x 10(-4) M) markedly attenuated the vasorelaxant effects of the endothelium-dependent vasodilator acetylcholine. In both arterioles, the inhibitory effect of N omega- nitro-L-arginine on acetylcholine-induced relaxation could be reversed by L- but not D-arginine (10(-3) M). However, N omega-nitro-L-arginine had no effect on the relaxation produced by the endothelium-independent vasodilators prostaglandin E2 (afferent) and dopamine (efferent). These observations demonstrate that under the in vitro conditions used in this study, afferent arterioles but not efferent arterioles synthesize and release nitric oxide in the basal state. However, both arterioles release nitric oxide in response to an endothelium-dependent vasodilator. The results of this study provide further evidence for an important role of nitric oxide in the regulation of renal hemodynamics.

This article has been cited by other articles:

				M. Herrera, P. A. Ortiz, and J. L. Garvin Regulation of thick ascending limb transport: role of nitric oxide Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1279 - F1284. [Abstract] [Full Text] [PDF]

				C. Delles and R. E. Schmieder Reply Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2925 - 2926. [Full Text] [PDF]

				C. Delles, A. U. Klingbeil, M. P. Schneider, R. Handrock, T. Schaufele, and R. E. Schmieder The role of nitric oxide in the regulation of glomerular haemodynamics in humans Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1392 - 1397. [Abstract] [Full Text] [PDF]

				P R J Ames, C Tommasino, J Alves, J D Morrow, L Iannaccone, G Fossati, S Caruso, F Caccavo, and V Brancaccio Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study Lupus, November 1, 2000; 9(9): 688 - 695. [Abstract] [PDF]

				D. L. Mattson and F. Wu Nitric Oxide Synthase Activity and Isoforms in Rat Renal Vasculature Hypertension, January 1, 2000; 35(1): 337 - 341. [Abstract] [Full Text] [PDF]

				C. G. Schnackenberg, F. C. Wilkins, and J. P. Granger Role of Nitric Oxide in Modulating the Vasoconstrictor Actions of Angiotensin II in Preglomerular and Postglomerular Vessels in Dogs Hypertension, December 1, 1995; 26(6): 1024 - 1029. [Abstract] [Full Text]

				H. Ono, Y. Ono, and E. D. Frohlich Nitric Oxide Synthase Inhibition in Spontaneously Hypertensive Rats : Systemic, Renal, and Glomerular Hemodynamics Hypertension, August 1, 1995; 26(2): 249 - 255. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673